首页 › 基金 › Concentric Capital Strategies, LP › BIO
Concentric Capital Strategies, LP 对 BIO 的持仓历史
BIO RAD LABS INC CL A · 工业
Concentric Capital Strategies, LP 在 Q2 2026 的 13F 申报中披露持有 BIO(BIO RAD LABS INC CL A)23,692 股,市值约 US$7.0M,约占其申报组合的 0.39%,在其申报持仓中市值排名第 45 位。 Concentric Capital Strategies, LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Concentric Capital Strategies, LP 对 BIO 的持仓演变
Concentric Capital Strategies, LP 于 Q2 2026 首次披露 BIO 持仓:23,692 股(约 US$7.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 23.69K | $6.96M | 新进 |
关于 BIO 与 13F 数据
BIO(BIO RAD LABS INC CL A)属于工业行业。我们追踪的基金中还有 23 只申报持有 BIO,申报仓位最大的包括:First Eagle 投资管理 (US$765.2M), ARIEL INVESTMENTS, LLC (US$239.8M), First Pacific Advisors, LP (US$118.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BIO 的基金
- First Eagle 投资管理 2.61M 股 · $765.21M · Q2 2026
- ARIEL INVESTMENTS, LLC 816.75K 股 · $239.81M · Q2 2026
- First Pacific Advisors, LP 401.86K 股 · $117.99M · Q2 2026
- NOMURA HOLDINGS INC 328.90K 股 · $96.57M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 226.07K 股 · $66.38M · Q2 2026
更多关于 Concentric Capital Strategies, LP
常见问题
How long has Concentric Capital Strategies, LP held BIO?
Concentric Capital Strategies, LP has disclosed BIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Concentric Capital Strategies, LP's current position in BIO?
As of Q2 2026, Concentric Capital Strategies, LP holds 23.69K shares of BIO (BIO RAD LABS INC CL A), valued at $6.96M, representing 0.39% of its reported portfolio and ranking #45.
Has Concentric Capital Strategies, LP been buying or selling BIO?
In the latest 13F filing (Q2 2026), Concentric Capital Strategies, LP newly opened its position in BIO.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle 投资管理, ARIEL INVESTMENTS, LLC, First Pacific Advisors, LP, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.